Étude rétrospective observationnelle sur l'usage des biomarqueurs du liquide céphalorachidien de la maladie d'Alzheimer

This study explored of the use of AD biomarker measures in clinical practice. While their implementation is currently focused on the diagnosis of AD at a mild stage, these biomarkers showed their usefulness in situations where the clinical diagnosis is made difficult by a psychiatric disorder and/or delirium, or when neuropsychological investigations are unfeasible.